Member-only story
Follicular Lymhoma with Transformation into Diffuse Large B-cell Lymphoma & Transdifferentiation into a Histiocytic/ Dendritic Neoplasm
Lessons From the Friday Unknows
Histologic examination reveals follicular lymphoma, grade 1–2 and grade 3A, with transformation into diffuse large B-cell lymphoma and transdifferentiation into histiocytic/dendritic cell neoplasm.
![](https://miro.medium.com/v2/resize:fit:700/1*-JyjxR0TR8XBL6Qwo8kFIQ.png)
Areas with follicular lymphoma, grade 1:
![](https://miro.medium.com/v2/resize:fit:700/1*V7qWpquBaf61UoK8aE3TkA.png)
Areas with diffuse large B-cell lymphoma:
![](https://miro.medium.com/v2/resize:fit:700/1*8svwLSTvnRYbsP2d87O_IA.png)
Areas with histiocytic/ dendritic cell tumor:
![](https://miro.medium.com/v2/resize:fit:700/1*qfrMRJgI_jwvyJpCN3h0SA.png)
Flow cytometric analysis revealed aberrant, kappa restricted B-cells positive for CD10 (dim), CD20 and FMC-7.
The follicular lymphoma and diffuse large B-cell lymphoma components are positive for CD20, CD79a, Pax-5, CD10, Bcl-2 and Bcl-6, with non-immunoreactivity for CD30, CD3 and CD5.
Cells within the separate histiocytic lesion are reported to have been positive for CD4, CD68, CD163, S-100 and lysozyme and negative for CD20, Pax-5, CD79a, CD1a, ALK-1, CD3, CD5, CD30 and CD21.
Link to digital slides: https://bit.ly/3kHiFSi | Slides labeled case 5